{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:07:04Z","timestamp":1790500024174,"version":"4.1.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.idc.2021.03.012","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T01:25:08Z","timestamp":1621301108000},"page":"493-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["Cryptococcosis"],"prefix":"10.1016","volume":"35","author":[{"given":"Alexis C.","family":"Gushiken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil K.","family":"Saharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Baddley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.idc.2021.03.012_bib1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CMR.8.4.515","article-title":"Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans","volume":"8","author":"Mitchell","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2021.03.012_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.fgb.2014.10.003","article-title":"Cryptococcosis diagnosis and treatment: what do we know now","volume":"78","author":"Perfect","year":"2015","journal-title":"Fungal Genet Biol"},{"issue":"8","key":"10.1016\/j.idc.2021.03.012_bib3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","article-title":"Cryptococcosis","volume":"30","author":"Maziarz","year":"2016","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/clinids\/21.1.28","article-title":"Clinical and host differences between infections with the two varieties of Cryptococcus neoformans","volume":"21","author":"Speed","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3201\/eid1602.090900","article-title":"Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007","volume":"16","author":"Galanis","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/clinids\/20.3.611","article-title":"Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome","volume":"20","author":"Mitchell","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s15010-007-6142-8","article-title":"Non-neoformans cryptococcal infections: a systematic review","volume":"35","author":"Khawcharoenporn","year":"2007","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","article-title":"Cryptococcus: from environmental saprophyte to global pathogen","volume":"14","author":"May","year":"2016","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2021.03.012_bib10","first-page":"1","article-title":"Cryptococcus gattii infections on Vancouver Island, British Columbia, Canada: emergence of a tropical fungus in a temperate environment","volume":"34","author":"Fyfe","year":"2008","journal-title":"Can Commun Dis Rep"},{"issue":"12","key":"10.1016\/j.idc.2021.03.012_bib11","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/cid\/cir723","article-title":"Cryptococcus gattii in the united states: clinical aspects of infection with an emerging pathogen","volume":"53","author":"Harris","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.03.012_bib12","doi-asserted-by":"crossref","first-page":"e74737","DOI":"10.1371\/journal.pone.0074737","article-title":"Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates","volume":"8","author":"Lockhart","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2021.03.012_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","article-title":"Recognition of seven species in the Cryptococcus gattii\/Cryptococcus neoformans species complex","volume":"78","author":"Hagen","year":"2015","journal-title":"Fungal Genet Biol"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib14","doi-asserted-by":"crossref","first-page":"e00357","DOI":"10.1128\/mSphere.00357-16","article-title":"The case for adopting the \u201cSpecies Complex\u201d nomenclature for the etiologic agents of Cryptococcosis","volume":"2","author":"Kwon-Chung","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.idc.2021.03.012_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fimmu.2018.00651","article-title":"Immunology of Cryptococcal infections: developing a rational approach to patient therapy","volume":"9","author":"Elsegeiny","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.idc.2021.03.012_bib16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2217\/fmb.14.132","article-title":"Host immunity to Cryptococcus neoformans","volume":"10","author":"Rohatgi","year":"2015","journal-title":"Future Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/cid\/cir756","article-title":"Cryptococcus gattii infection in healthy hosts: a sentinel for subclinical immunodeficiency?","volume":"54","author":"Marr","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2021.03.012_bib18","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti\u2013GM-CSF autoantibodies in patients with cryptococcal meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/21505594.2019.1614383","article-title":"Basic principles of the virulence of Cryptococcus","volume":"10","author":"Zaragoza","year":"2019","journal-title":"Virulence"},{"issue":"6","key":"10.1016\/j.idc.2021.03.012_bib20","doi-asserted-by":"crossref","first-page":"e1007144","DOI":"10.1371\/journal.ppat.1007144","article-title":"Cryptococcus neoformans urease affects the outcome of intracellular pathogenesis by modulating phagolysosomal pH","volume":"14","author":"Fu","year":"2018","journal-title":"PLOS Pathog"},{"issue":"21","key":"10.1016\/j.idc.2021.03.012_bib21","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.cub.2006.09.061","article-title":"Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages","volume":"16","author":"Alvarez","year":"2006","journal-title":"Curr Biol"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib22","doi-asserted-by":"crossref","first-page":"e02183","DOI":"10.1128\/mBio.02183-16","article-title":"Trojan horse transit contributes to blood-brain barrier crossing of a eukaryotic pathogen","volume":"8","author":"Santiago-Tirado","year":"2017","journal-title":"MBio"},{"issue":"4","key":"10.1016\/j.idc.2021.03.012_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3314\/mmj.19.008","article-title":"Cutaneous cryptococcosis","volume":"60","author":"Noguchi","year":"2019","journal-title":"Med Mycol J"},{"key":"10.1016\/j.idc.2021.03.012_bib24","doi-asserted-by":"crossref","first-page":"20977","DOI":"10.1038\/srep20977","article-title":"Cryptococcus neoformans thermotolerance to avian body temperature is sufficient for extracellular growth but not intracellular survival in macrophages","volume":"6","author":"Johnston","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/0003-4819-132-3-200002010-00006","article-title":"Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient","volume":"132","author":"Nosanchuk","year":"2000","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2021.03.012_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2796.2005.01466.x","article-title":"Zoonotic transmission of Cryptococcus neoformans from a magpie to an immunocompetent patient","volume":"257","author":"Lagrou","year":"2005","journal-title":"J\u00a0Intern Med"},{"issue":"6","key":"10.1016\/j.idc.2021.03.012_bib27","first-page":"606","article-title":"Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel","volume":"49","author":"Shrestha","year":"2004","journal-title":"Respir Care"},{"issue":"15","key":"10.1016\/j.idc.2021.03.012_bib28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM197804132981506","article-title":"Cryptococcal endophthalmitis after corneal transplantation","volume":"298","author":"Beyt","year":"1978","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2021.03.012_bib29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJM198507253130414","article-title":"Inoculation of Cryptococcosis without transmission of the acquired immunodeficiency syndrome","volume":"313","author":"Glaser","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2021.03.012_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/cid\/ciq216","article-title":"Transmission of Cryptococcus neoformans by organ transplantation","volume":"52","author":"Baddley","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tid.12836","article-title":"A\u00a0cluster of donor-derived Cryptococcus neoformans infection affecting lung, liver, and kidney transplant recipients: case report and review of literature","volume":"20","author":"Camargo","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2021.03.012_bib32","first-page":"1122","article-title":"Long-term mortality and disability in cryptococcal meningitis: a systematic literature review","volume":"66","author":"Pasquier","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2021.03.012_bib33","doi-asserted-by":"crossref","first-page":"e43582","DOI":"10.1371\/journal.pone.0043582","article-title":"Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative\/non-transplant","volume":"7","author":"Bratton","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.idc.2021.03.012_bib34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/myc.12496","article-title":"Cryptococcus neoformans infection in malignancy","volume":"59","author":"Schmalzle","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.idc.2021.03.012_bib35","doi-asserted-by":"crossref","first-page":"e00588","DOI":"10.1016\/j.idcr.2019.e00588","article-title":"Cognitive biases and knowledge deficits leading to delayed recognition of cryptococcal meningitis","volume":"18","author":"Deming","year":"2019","journal-title":"IDCases"},{"issue":"16","key":"10.1016\/j.idc.2021.03.012_bib36","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/QAD.0b013e3282a4a64d","article-title":"HIV-associated cryptococcal meningitis","volume":"21","author":"Jarvis","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2021.03.012_bib37","series-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases","first-page":"3154","article-title":"Cryptococcosis (Cryptococcus neoformans and Cryptococcus gattii)","author":"Perfect","year":"2020"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/313603","article-title":"Diagnosis and management of increased intracranial pressure in patients with AIDS and Cryptococcal Meningitis","volume":"30","author":"Graybill","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.012_bib39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/QCO.0000000000000315","article-title":"Repeated therapeutic lumbar punctures in cryptococcal meningitis-necessity and\/or opportunity?","volume":"29","author":"Chang","year":"2016","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/QAD.0b013e328333c005","article-title":"Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure","volume":"24","author":"Loyse","year":"2010","journal-title":"Aids"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0002-9343(91)90126-I","article-title":"Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome","volume":"91","author":"Denning","year":"1991","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of Cryptococcal disease: 2010 update by the infectious diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib43","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","article-title":"Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand","volume":"31","author":"Chen","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.03.012_bib44","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/cid\/civ041","article-title":"Longitudinal clinical findings and outcome among Cryptococcus gattii patients in British Columbia","volume":"60","author":"Phillips","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-80-2-176","article-title":"Prognostic factors in cryptococcal meningitis. A study in 111 cases","volume":"80","author":"Diamond","year":"1974","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.idc.2021.03.012_bib46","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/604716","article-title":"Independent Association between rate of clearance of infection and clinical outcome of HIV-Associated Cryptococcal Meningitis: analysis of a combined cohort of 262 patients","volume":"49","author":"Bicanic","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2021.03.012_bib47","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"01","key":"10.1016\/j.idc.2021.03.012_bib48","doi-asserted-by":"crossref","first-page":"069","DOI":"10.1055\/s-0039-3400280","article-title":"Cryptococcosis","volume":"41","author":"Zavala","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/mmy\/myy086","article-title":"Pulmonary cryptococcosis: a review of pathobiology and clinical aspects","volume":"57","author":"Setianingrum","year":"2019","journal-title":"Med Mycol"},{"key":"10.1016\/j.idc.2021.03.012_bib50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejrad.2017.02.008","article-title":"18F-FDG PET\/CT and contrast-enhanced CT findings of pulmonary cryptococcosis","volume":"89","author":"Wang","year":"2017","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.idc.2021.03.012_bib51","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/CMR.00126-13","article-title":"Cryptococcus gattii infections","volume":"27","author":"Chen","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1378\/chest.129.2.333","article-title":"Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients","volume":"129","author":"Chang","year":"2006","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.idc.2021.03.012_bib53","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.21037\/jtd.2016.10.36","article-title":"Clinical analysis of non-AIDS patients pathologically diagnosed with pulmonary cryptococcosis","volume":"8","author":"Liu","year":"2016","journal-title":"J\u00a0Thorac Dis"},{"issue":"1\u20132","key":"10.1016\/j.idc.2021.03.012_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11046-015-9880-7","article-title":"Systemic review of published reports on primary cutaneous cryptococcosis in immunocompetent patients","volume":"180","author":"Du","year":"2015","journal-title":"Mycopathologia"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archopht.1964.00970010068009","article-title":"Ophthalmologic complications of cryptococcal meningitis","volume":"71","author":"Okun","year":"1964","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.idc.2021.03.012_bib56","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00006982-200507000-00015","article-title":"HIV-associated retinopathy in the HAART era","volume":"25","author":"Goldberg","year":"2005","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.idc.2021.03.012_bib57","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/clinids\/14.5.1069","article-title":"Cryptococcal endophthalmitis: case report and review","volume":"14","author":"Crump","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2021.03.012_bib58","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3109\/09273940903003505","article-title":"Cryptococcal chorioretinitis with immune reconstitution inflammatory syndrome","volume":"17","author":"Shulman","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.pcan.4501031","article-title":"Granulomatous prostatitis due to Cryptococcus neoformans: diagnostic usefulness of special stains and molecular analysis of 18S rDNA","volume":"11","author":"Wada","year":"2008","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/0003-4819-111-2-125","article-title":"Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis","volume":"111","author":"Larsen","year":"1989","journal-title":"Ann Intern Med"},{"issue":"7\u20138","key":"10.1016\/j.idc.2021.03.012_bib61","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/myc.1990.33.7-8.369","article-title":"Persistence of Cryptococcus neoformans in seminal fluid and urine under itraconazole treatment. The urogenital tract (prostate) as a niche for Cryptococcus neoformans","volume":"33","author":"Staib","year":"1990","journal-title":"Mycoses"},{"issue":"DEC","key":"10.1016\/j.idc.2021.03.012_bib62","first-page":"1","article-title":"Skeletal cryptococcosis from 1977 to 2013","volume":"5","author":"Zhou","year":"2014","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2021.03.012_bib63","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/myc.12476","article-title":"Cryptococcal osteomyelitis: a report of 5 cases and a review of the recent literature","volume":"59","author":"Medaris","year":"2016","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib64","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.md.0000126760.45299.69","article-title":"Cryptococcus neoformans infection in patients with cirrhosis, including liver transplant candidates","volume":"83","author":"Singh","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.idc.2021.03.012_bib65","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1097\/TP.0000000000000690","article-title":"Cryptococcosis in patients with cirrhosis of the liver and posttransplant outcomes","volume":"99","author":"Singh","year":"2015","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib66","doi-asserted-by":"crossref","first-page":"e0190652","DOI":"10.1371\/journal.pone.0190652","article-title":"Evaluation of a point-of-care immunoassay test kit \u201cStrongStep\u201d for cryptococcal antigen detection","volume":"13","author":"Mpoza","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib67","doi-asserted-by":"crossref","first-page":"e01238","DOI":"10.1128\/JCM.01238-18","article-title":"Cryptococcal meningitis diagnostics and screening in the era of point-of-care laboratory testing","volume":"57","author":"Rajasingham","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2021.03.012_bib68","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1590\/S0036-46652009000500004","article-title":"Histopathology, serology and cultures in the diagnosis of cryptococcosis","volume":"51","author":"Gazzoni","year":"2009","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib69","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3201\/eid2001.130906","article-title":"Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast","volume":"20","author":"Boulware","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"suppl 19","key":"10.1016\/j.idc.2021.03.012_bib70","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1590\/S0036-46652015000700008","article-title":"Lateral flow assay for cryptococcal antigen: an important advance to improve the continuum of hiv care and reduce cryptococcal meningitis-related mortality","volume":"57","author":"Vidal","year":"2015","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib71","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/tid.12370","article-title":"Cryptococcus gattii infection in solid organ transplant recipients: description of Oregon outbreak cases","volume":"17","author":"Forrest","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2021.03.012_bib72","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1128\/JCM.00751-17","article-title":"Low cryptococcus antigen titers as determined by lateral flow assay should be interpreted cautiously in patients without prior diagnosis of cryptococcal infection","volume":"55","author":"Dubbels","year":"2017","journal-title":"J\u00a0Clin Microbiol"},{"issue":"12","key":"10.1016\/j.idc.2021.03.012_bib73","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1128\/JCM.01683-14","article-title":"Rapid diagnosis of cryptococcal meningitis by use of lateral flow assay on cerebrospinal fluid samples: influence of the high-dose \u201chook\u201d effect","volume":"52","author":"Lourens","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib74","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/cid\/civ263","article-title":"Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study","volume":"61","author":"Williams","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2021.03.012_bib75","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1093\/cid\/ciy817","article-title":"Symptomatic cryptococcal antigenemia presenting as early cryptococcal meningitis with negative cerebral spinal fluid analysis","volume":"68","author":"Ssebambulidde","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"9983","key":"10.1016\/j.idc.2021.03.012_bib76","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial","volume":"385","author":"Mfinanga","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.idc.2021.03.012_bib77","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/mmy\/myv104","article-title":"Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis","volume":"54","author":"Dyal","year":"2016","journal-title":"Med Mycol"},{"issue":"4","key":"10.1016\/j.idc.2021.03.012_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.01927-17","article-title":"Evaluation of a commercial multiplex molecular panel for diagnosis of infectious meningitis and encephalitis","volume":"56","author":"Liesman","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2021.03.012_bib79","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/cid\/ciy1024","article-title":"Detection of Cryptococcus DNA by metagenomic next-generation sequencing in symptomatic cryptococcal antigenemia","volume":"68","author":"Ramachandran","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.03.012_bib80","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/ctr.13543","article-title":"Cryptococcosis in solid organ transplantation\u2014guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Baddley","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.idc.2021.03.012_bib81","series-title":"Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and Children: Supplement to the 2016 consolidated guidelines on the Use of antiretroviral drugs for treating and preventing HIV infection","year":"2018"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib82","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A\u00a0comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis","volume":"301","author":"Bennett","year":"1979","journal-title":"N\u00a0Engl J Med"},{"issue":"9423","key":"10.1016\/j.idc.2021.03.012_bib83","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"Brouwer","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.idc.2021.03.012_bib84","doi-asserted-by":"crossref","first-page":"e2870","DOI":"10.1371\/journal.pone.0002870","article-title":"Major role for amphotericin B-flucytosine combination in severe cryptococcosis","volume":"3","author":"Dromer","year":"2008","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.idc.2021.03.012_bib85","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.idc.2021.03.012_bib86","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal combinations for treatment of cryptococcal meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib87","doi-asserted-by":"crossref","first-page":"e25416","DOI":"10.1002\/jia2.25416","article-title":"Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysis","volume":"23","author":"Tenforde","year":"2020","journal-title":"J\u00a0Int AIDS Soc"},{"issue":"12","key":"10.1016\/j.idc.2021.03.012_bib88","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00002030-199712000-00010","article-title":"Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis","volume":"11","author":"Leenders","year":"1997","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib89","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/653606","article-title":"Comparison of 2 doses of liposomal amphotericin b and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety","volume":"51","author":"Hamill","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib90","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00705-08","article-title":"Antifungal therapeutic drug monitoring: established and emerging indications","volume":"53","author":"Andes","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib91","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/infdis\/jit164","article-title":"Pharmacodynamics of liposomal amphotericin b and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients","volume":"208","author":"O\u2019Connor","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib92","doi-asserted-by":"crossref","first-page":"ofu070","DOI":"10.1093\/ofid\/ofu070","article-title":"Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings","volume":"1","author":"Bahr","year":"2014","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2021.03.012_bib93","article-title":"Treatment for HIV-associated cryptococcal meningitis","volume":"7","author":"Tenforde","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib94","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi","volume":"50","author":"Nussbaum","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2021.03.012_bib95","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/507895","article-title":"Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution","volume":"43","author":"Bicanic","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.012_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.02575-19","article-title":"Fluconazole monotherapy is a suboptimal option for initial treatment of cryptococcal meningitis because of emergence of resistance","volume":"10","author":"Hope","year":"2019","journal-title":"MBio"},{"key":"10.1016\/j.idc.2021.03.012_bib97","series-title":"Identifier NCT00885703, high-dose fluconazole for the treatment of cryptococcal meningitis in HIV-infected individuals","year":"2010"},{"issue":"6","key":"10.1016\/j.idc.2021.03.012_bib98","doi-asserted-by":"crossref","first-page":"e00090","DOI":"10.1128\/AAC.00090-17","article-title":"Experimental models of short courses of liposomal Amphotericin B for induction therapy for cryptococcal meningitis","volume":"61","author":"Lestner","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib99","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/ciy515","article-title":"Short-course high-dose liposomal amphotericin b for human immunodeficiency virus-associated cryptococcal meningitis: a phase 2 randomized controlled trial","volume":"68","author":"Jarvis","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.03.012_bib100","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM199102283240902","article-title":"A\u00a0placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome","volume":"324","author":"Bozzette","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.idc.2021.03.012_bib101","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/322597","article-title":"Cryptococcosis in human immunodeficiency virus\u2013negative patients in the era of effective azole therapy","volume":"33","author":"Pappas","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2021.03.012_bib102","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199203193261203","article-title":"A\u00a0controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group","volume":"326","author":"Powderly","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib103","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/515110","article-title":"A\u00a0comparison of Itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis","volume":"28","author":"Saag","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib104","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.01216-08","article-title":"Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans","volume":"53","author":"Thompson","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"26","key":"10.1016\/j.idc.2021.03.012_bib105","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"370","author":"Boulware","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2021.03.012_bib106","article-title":"Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis","volume":"7","author":"Eshun-Wilson","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib107","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/QCO.0b013e32835c21d1","article-title":"Cryptococcal immune reconstitution inflammatory syndrome","volume":"26","author":"Longley","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2021.03.012_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1000384","article-title":"Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study","volume":"7","author":"Boulware","year":"2010","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.idc.2021.03.012_bib109","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.tp.0000180530.17683.02","article-title":"Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome","volume":"80","author":"Singh","year":"2005","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/cid\/ciu711","article-title":"Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression","volume":"60","author":"Sun","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hiv.12676","article-title":"Shedding light on IRIS: from pathophysiology to treatment of cryptococcal meningitis and immune reconstitution inflammatory syndrome in HIV-infected individuals","volume":"20","author":"Balasko","year":"2019","journal-title":"HIV Med"},{"issue":"13","key":"10.1016\/j.idc.2021.03.012_bib112","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1097\/QAD.0b013e3283614a8d","article-title":"Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome","volume":"27","author":"Chang","year":"2013","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.idc.2021.03.012_bib113","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/655785","article-title":"Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory Syndrome","volume":"202","author":"Boulware","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.03.012_bib114","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","article-title":"Incidence and lethality of immune reconstitution disease in HIV-infected patients starting antiretroviral therapy: systematic review and meta-analysis","volume":"10","author":"M\u00fcller","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofv194","article-title":"Human immune response varies by the degree of relative cryptococcal antigen shedding","volume":"3","author":"Boulware","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2021.03.012_bib116","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/cid\/cit019","article-title":"Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and Cryptococcal Meningitis","volume":"56","author":"Bisson","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.012_bib117","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(07)70085-3","article-title":"Immune reconstitution syndrome associated with opportunistic mycoses","volume":"7","author":"Singh","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2021.03.012_bib118","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/430606","article-title":"An immune reconstitution syndrome-like Illness Associated with Cryptococcus neoformans infection in organ transplant recipients","volume":"40","author":"Singh","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.012_bib119","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive dexamethasone in HIV-associated cryptococcal meningitis","volume":"374","author":"Beardsley","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.idc.2021.03.012_bib120","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1086\/647948","article-title":"Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis","volume":"49","author":"Sun","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2021.03.012_bib121","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/01.tp.0000173774.74388.49","article-title":"Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection","volume":"80","author":"Singh","year":"2005","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib122","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/cid\/cir276","article-title":"Opportunistic infection-associated immune reconstitution syndrome in transplant recipients","volume":"53","author":"Sun","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2021.03.012_bib123","series-title":"Emerging transplant infections: clinical challenges and Implications","first-page":"1","article-title":"Management of Cryptococcosis in transplant candidates and recipients","author":"Baddley","year":"2020"},{"issue":"2","key":"10.1016\/j.idc.2021.03.012_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.idc.2021.03.012_bib125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/QCO.0000000000000593","article-title":"Primary immunodeficiencies and invasive fungal infection: when to suspect and how to diagnose and manage","volume":"32","author":"Lionakis","year":"2019","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.012_bib126","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJM198708063170602","article-title":"Treatment of Cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks","volume":"317","author":"Dismukes","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.idc.2021.03.012_bib127","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/cid\/ciu596","article-title":"The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis","volume":"59","author":"Rolfes","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.012_bib128","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/342299","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis","volume":"35","author":"Newton","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib129","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1473-3099(14)70945-4","article-title":"Management of Cryptococcus gattii meningoencephalitis","volume":"15","author":"Franco-Paredes","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.03.012_bib130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cit341","article-title":"Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii","volume":"57","author":"Chen","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.03.012_bib131","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/603554","article-title":"Dexamethasone in Cryptococcus gattii central nervous system infection","volume":"49","author":"Phillips","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib132","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0035-9203(97)90393-X","article-title":"The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis","volume":"91","author":"Seaton","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.idc.2021.03.012_bib133","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-94-5-611","article-title":"The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors","volume":"94","author":"Kerkering","year":"1981","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib134","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1378\/chest.115.3.734","article-title":"Pulmonary cryptococcosis in patients without HIV infection","volume":"115","author":"Aberg","year":"1999","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.idc.2021.03.012_bib135","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2217\/fvl.13.71","article-title":"Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysis","volume":"8","author":"Ssekitoleko","year":"2013","journal-title":"Future Virol"},{"issue":"3","key":"10.1016\/j.idc.2021.03.012_bib136","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1615822","article-title":"Europe PMC funders group enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa","volume":"377","author":"Hakim","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2021.03.012_bib137","article-title":"Primary antifungal prophylaxis for cryptococcal disease in HIV-positive people","volume":"8","author":"Awotiwon","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.idc.2021.03.012_bib138","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","article-title":"Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults","volume":"16","author":"French","year":"2002","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.idc.2021.03.012_bib139","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/cid\/cix872","article-title":"High cryptococcal antigen titers in blood are predictive of subclinical cryptococcal meningitis among human immunodeficiency virus-infected patients","volume":"66","author":"Wake","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"suppl_2","key":"10.1016\/j.idc.2021.03.012_bib140","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/cid\/cix1143","article-title":"CD4 Cell count threshold for cryptococcal antigen screening of HIV-infected individuals: a systematic review and meta-analysis","volume":"66","author":"Ford","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.idc.2021.03.012_bib141","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1097\/QAI.0000000000000484","article-title":"Cryptococcal antigen screening and early antifungal treatment to prevent cryptococcal meningitis: a review of the literature","volume":"68","author":"Kaplan","year":"2015","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1016\/j.idc.2021.03.012_bib142","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cid\/civ936","article-title":"Cryptococcal antigen screening in patients initiating ART in South Africa: a prospective cohort study","volume":"62","author":"Longley","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.012_bib143","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/cid\/ciu937","article-title":"Prevalence, correlates, and outcomes of Cryptococcal antigen positivity among patients with AIDS, United States, 1986\u20132012","volume":"60","author":"McKenney","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2021.03.012_bib144","doi-asserted-by":"crossref","first-page":"e69288","DOI":"10.1371\/journal.pone.0069288","article-title":"Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa","volume":"8","author":"Jarvis","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.idc.2021.03.012_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0210105","article-title":"Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: a cost-effectiveness modeling analysis","volume":"14","author":"Rajasingham","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.idc.2021.03.012_bib146","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/cid\/cis725","article-title":"Reconsidering Cryptococcal antigen screening in the U.S. among persons with CD4\u00a0<100 cells\/mcL","volume":"55","author":"Rajasingham","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.03.012_bib147","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/j.1600-6143.2012.04100.x","article-title":"Donor-derived fungal infections in organ transplant recipients: guidelines of the American society of transplantation, infectious diseases community of practice","volume":"12","author":"Singh","year":"2012","journal-title":"Am J Transplant"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552021000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552021000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:31:46Z","timestamp":1760196706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552021000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":147,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0891552021000222"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2021.03.012","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryptococcosis","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2021.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}